|
|
|
|
|
Legal status
Patent in force
| (51) | INT.CL. | C07K 16/28 | (2006.01) |
| G01N 33/00 | (2006.01) | ||
| C07K 16/00 | (2006.01) |
| (11) | Number of the document | 2044121 |
| (13) | Kind of document | T |
| (96) | European patent application number | 07801422.2 |
| Date of filing the European patent application | 2007-07-11 | |
| (97) | Date of publication of the European application | 2009-04-08 |
| (45) | Date of publication and mention of the grant of the patent | 2013-08-21 |
| (46) | Date of publication of the claims translation | 2013-12-27 |
| (86) | Number | PCT/EP2007/006123 |
| Date | 2007-07-11 |
| (87) | Number | WO 2008/006554 |
| Date | 2008-01-17 |
| (30) | Number | Date | Country code |
| 06450095 | 2006-07-11 | EP |
| (72) |
SCHUSTER, Manfred, AT
KIRCHEIS, Ralf, AT
NECHANSKY, Andreas, AT
JOST, Wolfgang, DE
GORR, Gilbert, DE
|
| (73) |
Greenovation Biotech GmbH,
Bötzinger Strasse 29b, 79111 Freiburg i.Br,
DE
|
| (74) |
Marius JAKULIS - JASON,
AAA Law, A. Goštauto g. 40B, Verslo centras "Dvyniai", LT-03163 Vilnius,
LT
|
| (54) | Gliko-modifikuoti antikūnai |
| GLYCO-ENGINEERED ANTIBODIES |
| Payment date | Validity (years) | Amount | |
| 2025-06-26 | 19 | 347.00 EUR |
| 2026-07-11 |